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Summary  A  62-year-old  woman  complained  of  sudden  chest  pain  and  64-multidetector  row
computed tomography  (MDCT)  was  performed.  The  volume-rendered  image  showed  severe
stenosis of  the  left  main  coronary  trunk  artery  (LMT).  The  mean  density  of  the  plaque  was
32.4 hounsﬁeld  units  (HU),  which  indicated  soft  plaque.  Coronary  angiography  (CAG)  showed
signiﬁcant  focal  stenosis  of  the  LMT.  Since  the  patient  had  experienced  chest  pain,  and  since
focal stenosis  of  the  LMT  was  demonstrated,  lipid-lowering  therapy  using  statin  and  coronary
artery bypass  graft  (CABG,  right  internal  mammary  artery-left  anterior  descending  branch,  left
internal mammary  artery-obtuse  marginal  branch)  were  applied.  Three  years  after  treatment,
64-MDCT  showed  mild  stenosis  and  a  regression  of  plaque  in  the  LMT.  The  mean  density  of  the
plaque was  73.1  HU  (intermediate  plaque).  CAG  showed  a  degradation  of  CABG  ﬂow,  in  addition
to mild  stenosis  of  the  LMT.  In  conclusion,  lipid-lowering  therapy  with  statins  may  stabilize  soft
coronary plaque.  In  addition,  non-invasive  MDCT  is  a  useful  tool  for  diagnosing  coronary  artery
disease,  and  for  evaluating  the  size  and  properties  of  coronary  plaque.
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therosclerotic  plaque  is  usually  considered  to  build  up
lowly.  Some  cases  of  regression  of  plaque  have  been
eported  worldwide  [1].  Lipid-lowering  therapy  using  statins
as  been  shown  to  reduce  the  risk  of  coronary  artery  disease
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nd  other  complications  [2].  In  addition,  coronary  artery
laque  can  be  imaged  noninvasively  and  assessed  by  mul-
idetector  row  computed  tomography  (MDCT).
MDCT  has  been  recognized  as  an  important  resource  for
he  evaluation  of  known  or  suspected  coronary  artery  dis-
ase,  especially  for  non-calciﬁed  lesions,  and  can  also  be
sed  to  assess  anomalies  of  the  aorta,  pulmonary  artery,
ther  vascular  structures,  and  cardiac  chambers  [3,4]. We
eport  here  a  case  of  regression  and  a  change  in  the  vulner-
bility  of  coronary  plaque  in  the  left  main  coronary  trunk
rtery  (LMT)  after  statin  treatment  and  coronary  artery
ypass  graft  (CABG).
 Published by Elsevier Ltd. All rights reserved.
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Case report
A  62-year-old  woman  was  brought  to  an  emergency  room
complaining  of  sudden  chest  pain  at  night.  She  had  never
experienced  chest  pain  before.  This  symptom  disappeared
with  the  perlingual  administration  of  nitroglycerin  0.3  mg.
However,  this  symptom  increased  the  same  night,  and  she
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Table  1  Characteristics  of  coronary  plaque  and  lipid  proﬁle  befo
Befor
MDCT  (LMT,  cross-sectional  image)
Plaque
Density,  HU  73.1  
Size, cm2 20.7  
Lipid proﬁle
TC,  mg/dL  204  
TG, mg/dL  247  
HDL-C, mg/dL  44  
LDL-C, mg/dL  133  
Non-HDL, mg/dL  160  
L/H ratio  3.02  
CABG, coronary artery bypass graft; MDCT, multidetector row computed
units; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipopr
ratio, the ratio of LDL-C to HDL-C.
Figure  1  Volume-rendered  (A)  and  multi-planar  reconstructed  (B)  
nary artery  bypass  graft  and  3  years  later.  RCA,  right  coronary  art
descending artery;  LCX,  left  circumﬂex  artery. e93
as  brought  to  our  emergency  room  the  next  day.  She  had  a
istory  of  dyslipidemia,  but  no  history  of  hypertension,  dia-
etes  mellitus,  or  smoking.  With  regard  to  the  lipid  proﬁle
Table  1),  total  cholesterol  (TC)  was  204  mg/dL,  triglyceride
TG)  was  247  mg/dL,  high-density  lipoprotein  cholesterol
HDL-C)  was  44  mg/dL,  low-density  lipoprotein  cholesterol
LDL-C)  was  133  mg/dL,  and  the  ratio  of  LDL-C  to  HDL-C
re  CABG  and  3  years  later.
e  CABG  3  years  later
32.4
4.26
198
144
51
109
147
1.98
 tomography; LMT, left main coronary trunk artery; HU, hounsﬁeld
otein cholesterol; LDL-C, low-density lipoprotein cholesterol L/H
multi-detector  row  computed  tomography  images  before  coro-
ery;  LMT,  left  main  coronary  trunk  artery;  LAD,  left  anterior
e94  Y.  Shiga  et  al.
Figure  2  Coronary  angiographic  images  before  coronary  artery  bypass  graft  (CABG)  and  3  years  later  (A)  coronary  artery;  (B)
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nABG. CABG  [right  internal  mammary  artery  (RITA)  —  left  anteri
arginal branch]  was  performed.  LMT,  left  main  coronary  trunk
L/H)  was  3.02.  Her  blood  pressure  was  110/68  mmHg  with-
ut  any  laterality.  Her  heart  rate  was  72  beats/min,  regular.
he  had  no  cardiac  murmur.  Electrocardiogram  showed  nor-
al  sinus  rhythm  and  ST  depression  in  leads  I  and  V5-6.  Chest
-ray  showed  a  normal  cardiac  silhouette  (cardiothoracic
atio  50.0%).  Transthoracic  echocardiogram  showed  normal
eft  ventricular  systolic  function  (left  ventricular  ejection
raction  58%)  and  no  asynergy.  Further  investigation  was  per-
ormed  using  64-MDCT  (Aquilion  64,  TOSHIBA,  Tokyo,  Japan)
nd  a  workstation  (ZIO  STATION,  ZIO  SOFT,  Tokyo,  Japan)  [5].
he  volume-rendered  image  showed  severe  stenosis  of  the
MT  (Fig.  1A).  Multi-planar  reconstruction  revealed  a  sim-
lar  ﬁnding  (Fig.  1B),  and  a  cross-sectional  image  showed
evere  stenosis  with  plaque  in  the  LMT  (Table  1).  The  mean
ensity  of  the  plaque  was  32.4  hounsﬁeld  units  (HU).  Coro-
ary  angiography  showed  signiﬁcant  focal  90%  stenosis  of
he  LMT  (Fig.  2).  Since  focal  stenosis  of  the  LMT  was  demon-
trated,  lipid-lowering  therapy  (pravastatin  5.0  mg/day),
ntiplatelet  therapy  (aspirin  100  mg/day),  and  CABG  (right
nternal  mammary  artery  —  left  anterior  descending
ranch,  left  internal  mammary  artery  —  obtuse  marginal
ranch)  were  applied.  The  use  of  diltiazem  hydrochloride
100  mg/day)  as  a  calcium  channel  blocker  was  stopped  after
ABG,  and  pitavastatin  (2  mg/day)  was  started  after  CABG.
Three  years  after  CABG,  she  experienced  chest  pain
gain.  TC  was  198  mg/dL,  TG  was  144  mg/dL,  HDL-C  was
t
s
r
cscending  branch,  left  internal  mammary  artery  (LITA)  —  obtuse
ry.
1 mg/dL,  LDL-C  was  109  mg/dL,  and  L/H  ratio  was  1.98
fter  lipid-lowering  therapy.  64-MDCT  showed  mild  steno-
is  and  regression  of  plaque  in  the  LMT.  The  mean  density
f  the  plaque  was  73.1  HU.  Coronary  angiography  showed
egradation  of  CABG  ﬂow,  in  addition  to  25%  stenosis  of  the
MT  detected  by  MDCT  (Fig.  2).
iscussion
his  patient  represents  a  case  of  regression  of  coronary
laque  in  the  LMT  after  CABG  and  statin  treatment.  Gen-
rally,  the  regression  of  plaques  is  caused  by  lipid-lowering
herapy.  The  levels  of  L/H  ratio  are  independent  risk  factors
or  coronary  artery  disease.  Lower  values  for  the  ratio  of
/H  in  addition  to  a  greater  percentage  increase  in  HDL-C
nd  lower  levels  of  LDL-C  in  patients  during  treatment  with
tatins  have  been  associated  with  the  regression  of  atheroma
6,7].  Few  reports  have  discussed  whether  L/H  ratio  or  non-
DL-C  (TC  minus  HDL-C)  is  a  risk  factor  [6,8], although  we
reviously  determined,  among  the  levels  of  LDL-C,  HDL-C,
on-HDL-C,  and  L/H  ratio,  which  is  most  closely  related  to
he  presence  of  coronary  artery  disease  [9].  There  have  been
ome  reports  of  the  regression  of  plaque  in  patients  with  L/H
atio  under  1.5  [6,7]. The  value  of  L/H  ratio  in  the  present
ase  did  not  fall  below  1.5  (from  3.02  to  1.98).  Since  this
graft
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case  has  no  other  coronary  risk  factors,  including  hyperten-
sion,  diabetes  mellitus,  or  smoking,  and  since  this  case  had
soft  plaque,  we  thought  that  lipid-lowering  therapy  may  be
signiﬁcant.
MDCT  has  been  previously  used  to  diagnose  atheroscle-
rotic  plaque  [10,11].  It  has  been  reported  that  the  mean
density  of  soft  plaque  was  14  ±  26  HU  (−14  to  +47  HU),  that
of  intermediate  plaque  was  91  ±  21  HU  (61—112  HU),  and
that  of  calciﬁed  plaque  was  419  ±  194  HU  (126—736  HU)  [12].
In  this  case,  the  mean  density  of  plaque  by  MDCT  before
treatment  was  32.4  HU.  This  plaque  was  classiﬁed  as  soft
plaque  that  is  prone  to  acute  coronary  syndrome  and  more
vulnerable  to  rupture  [13]. Three  years  after  treatment,  the
mean  density  of  plaque  by  MDCT  increased  to  73.1  HU,  which
is  considered  to  be  intermediate  plaque.  This  increase  shows
that  the  plaque  vulnerability  was  stabilized  after  treatment.
MDCT  may  become  a  useful  tool  for  studying  the  course  of
coronary  plaque  size  and  vulnerability,  and  the  effect  of
lipid-lowering  therapy  [14].
Although  we  thought  that  chest  pain  3  years  after  CABG
may  have  been  caused  by  coronary  spasm,  we  did  not
perform  Holter  electrocardiography,  treadmill  test,  and/or
provocation  test.  She  may  have  had  coronary  spasm  because
the  complaint  ‘‘sudden  chest  pain  at  night’’  was  relieved  by
nitroglycerin  0.3  mg  at  ﬁrst  visit  and  she  had  never  experi-
enced  effort  chest  pain.
In  conclusion,  lipid-lowering  therapy  using  statin  may  sta-
bilize  soft  coronary  plaque.  Non-invasive  MDCT  is  a  useful
tool  for  diagnosing  coronary  artery  disease,  and  for  apprais-
ing  the  size  and  vulnerability  of  coronary  plaque.
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